A Study of Counseling Support for Cancer Survivors Age 65+

Part of paid clinical trials in Basking Ridge, New Jersey.

Sponsor
Memorial Sloan Kettering Cancer Center
Study ID
NCT07768449
Status
Recruiting

Conditions

  • Cancer Survivors

Eligibility Criteria

Sex
ALL
Age
65 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • assessments (questionnaires) — OTHER
    Complete assessments (questionnaires) before the intervention begins (at baseline), after the last session (around Week 10) and a follow-up assessment at Week 18 (or approximately 2 months after the sessions end.

Study Details

The purpose of this study is to find out if a psychotherapy method called brief behavioral activation (BBA) can improve depression, anxiety, and overall well-being and encourage healthy lifestyle behaviors in English- and Spanish-speaking Older Adult Cancer Survivors (OACS). BBA is a therapeutic technique that guides people to set goals and engage in enjoyable or rewarding activities as a way of changing behavior and reducing symptoms of depression. In this study, BBA will be given by telephone or videoconference (remotely).

Key Dates

First listed
Aug 17, 2026
Start date
Aug 10, 2026
Status verified
Aug 2026
Primary completion
Aug 31, 2030
Completion
Aug 31, 2030

Study Design

Enrollment
454 participants (estimated)
Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Behavioral Activation for Older Adult Cancer Survivor ( BBA-OAC)
    Involves 10 30-50-minute telephone and/or video-conference sessions with structured agendas for interventionists consisting of: 1. Psychoeducation about depression and the rationale for BBA-OACs, and invitation to share one's cancer story and ongoing medical and psychosocial concerns 2. Compilation of a list of pleasant and rewarding social, physical, and recreational activities in line with participants' values 3. Daily activity scheduling; and 4. Self-monitoring of satisfaction and mood
  • Active Comparator: Supportive Psychotherapy (SP)
    Full SP participants (not training case participants) will also complete 10 sessions, 30-50 minutes each, over the telephone or video-conference with SP-trained interventionists.

Primary Outcome Measure

change in Patient Health Questionnaire 9 (PHQ-9 at T2) [ Time Frame: 1 year ]

Central Contacts

Locations (7)

FacilityCityStateZIPSite coordinators
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)Basking RidgeNew Jersey07920
Rebecca Saracino, PhD
646-888-0263
Memorial Sloan Kettering at Monmouth (Limited Protocol Activities)MiddletownNew Jersey07748
Rebecca Saracino, PhD
646-888-0263
Memorial Sloan Kettering at Bergen (Limited Protocol Activities)MontvaleNew Jersey07645
Rebecca Saracino, PhD
646-888-0263
Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities)CommackNew York11725
Rebecca Saracino, PhD
646-888-0263
Memorial Sloan Kettering at Westchester (Limited Protocol Activities)HarrisonNew York10604
Rebecca Saracino, PhD
646-888-0263
Memorial Sloan Kettering Cancer CenterNew YorkNew York10065
Rebecca Saracino, PhD
646-888-0263
Devika Jutagir, PhD
646-888-8361
Memorial Sloan Kettering at Nassau (Limited Protocol Activities)UniondaleNew York11553
Rebecca Saracino, PhD
646-888-0263

Find similar trials in Basking Ridge, NJ

Related Studies